A Hybrid Intelligence Approach for Circulating Tumor Cell Enumeration in Digital Pathology by Using CNN and Weak
1Conestoga High School, Berwyn, PA 19087, USA.
Summary
This study introduces a hybrid AI system combining deep learning and expert knowledge for automated Circulating Tumor Cell (CTC) counting in cancer screening. The novel approach significantly reduces counting errors compared to traditional methods.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Computational Biology
Background:
- Manual counting of Circulating Tumor Cells (CTCs) for cancer screening is labor-intensive.
- Deep learning (DL) shows promise in medical image analysis.
Purpose of the Study:
- To develop a hybrid AI system for automated CTC enumeration.
- To combine cytopathologist expertise with DL Convolutional Neural Networks (CNNs).
Main Methods:
- Developed a three-component hybrid system: CNN-based detection/localization (weak annotations), CNN-based segmentation, and Support Vector Machine (SVM) classification.
- Utilized B-scale transform for sphericality, incorporating size, texture, and area for SVM input.
- Trained and validated on fluoroscopic images for CTC detection, segmentation, and enumeration.
Main Results:
- Achieved high precision (0.98) and recall (0.92) for CTC detection, comparable to state-of-the-art methods.
- Demonstrated a low counting error of 2-3% (with B-scale) on an independent dataset.
- Outperformed previous thresholding methods (30% error) significantly.
Conclusions:
- The hybrid AI approach offers an efficient and accurate method for CTC enumeration.
- This system has the potential to reduce the time and cost associated with cancer screening.
- Further research in object localization and segmentation is supported by these findings.
More Related Videos
14:14Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
15.8K
05:17Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
8.6K
